Penumbra EBITDA Margin 2014-2023 | PEN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Penumbra (PEN) over the last 10 years. The current EBITDA margin for Penumbra as of December 31, 2023 is .
| Penumbra EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $1.06B | $0.10B | 9.64% |
| 2023-09-30 | $0.99B | $0.07B | 7.14% |
| 2023-06-30 | $0.94B | $0.06B | 6.72% |
| 2023-03-31 | $0.88B | $0.04B | 4.98% |
| 2022-12-31 | $0.85B | $0.03B | 3.66% |
| 2022-09-30 | $0.83B | $-0.01B | -1.69% |
| 2022-06-30 | $0.81B | $-0.01B | -1.74% |
| 2022-03-31 | $0.78B | $-0.01B | -0.77% |
| 2021-12-31 | $0.75B | $0.01B | 1.20% |
| 2021-09-30 | $0.71B | $0.05B | 6.34% |
| 2021-06-30 | $0.67B | $0.02B | 2.38% |
| 2021-03-31 | $0.59B | $-0.01B | -1.69% |
| 2020-12-31 | $0.56B | $-0.02B | -4.11% |
| 2020-09-30 | $0.54B | $-0.01B | -2.23% |
| 2020-06-30 | $0.53B | $0.02B | 3.80% |
| 2020-03-31 | $0.56B | $0.05B | 8.45% |
| 2019-12-31 | $0.55B | $0.06B | 10.24% |
| 2019-09-30 | $0.52B | $0.05B | 9.75% |
| 2019-06-30 | $0.50B | $0.02B | 3.43% |
| 2019-03-31 | $0.47B | $0.01B | 2.76% |
| 2018-12-31 | $0.45B | $0.01B | 1.12% |
| 2018-09-30 | $0.42B | $0.00B | 0.48% |
| 2018-06-30 | $0.39B | $0.02B | 5.85% |
| 2018-03-31 | $0.36B | $0.01B | 3.30% |
| 2017-12-31 | $0.33B | $0.01B | 1.80% |
| 2017-09-30 | $0.31B | $0.00B | 0.32% |
| 2017-06-30 | $0.29B | $-0.00B | -0.34% |
| 2017-03-31 | $0.28B | $-0.00B | -0.36% |
| 2016-12-31 | $0.26B | $0.00B | 1.14% |
| 2016-09-30 | $0.24B | $0.01B | 2.05% |
| 2016-06-30 | $0.23B | $0.01B | 3.52% |
| 2016-03-31 | $0.20B | $0.01B | 2.45% |
| 2015-12-31 | $0.19B | $0.01B | 3.24% |
| 2015-06-30 | $0.11B | $0.00B | 0.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.077B | $1.059B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $208.893B | 25.41 |
| Intuitive Surgical (ISRG) | United States | $132.624B | 82.78 |
| Edwards Lifesciences (EW) | United States | $52.512B | 34.76 |
| DexCom (DXCM) | United States | $51.605B | 88.65 |
| IQVIA Holdings (IQV) | United States | $41.246B | 24.46 |
| IDEXX Laboratories (IDXX) | United States | $39.720B | 47.49 |
| Alcon (ALC) | Switzerland | $38.955B | 28.73 |
| STERIS (STE) | Ireland | $19.787B | 23.42 |
| Waters (WAT) | United States | $18.041B | 25.89 |
| Hologic (HOLX) | United States | $17.586B | 19.41 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.281B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.247B | 84.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.132B | 13.75 |
| Sysmex ADR (SSMXY) | Japan | $9.874B | 30.97 |
| Teleflex (TFX) | United States | $9.811B | 15.41 |
| Masimo (MASI) | United States | $7.229B | 40.54 |
| Globus Medical (GMED) | United States | $6.931B | 21.97 |
| Glaukos (GKOS) | United States | $4.863B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.971B | 25.38 |
| TransMedics (TMDX) | United States | $2.874B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.799B | 18.46 |
| PROCEPT BioRobotics (PRCT) | United States | $2.639B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.635B | 18.08 |
| Integra LifeSciences Holdings (IART) | United States | $2.511B | 10.30 |
| Nihon Kohden (NHNKY) | Japan | $2.303B | 19.48 |
| Inari Medical (NARI) | United States | $2.243B | 387.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.050B | 0.00 |
| RxSight (RXST) | United States | $1.954B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.726B | 0.00 |
| Veracyte (VCYT) | United States | $1.416B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.864B | 15.99 |
| Artivion (AORT) | United States | $0.822B | 94.95 |
| Paragon 28 (FNA) | United States | $0.807B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.711B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.704B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.684B | 0.00 |
| SiBone (SIBN) | United States | $0.625B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.546B | 18.52 |
| IRadimed (IRMD) | United States | $0.513B | 29.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
| Nevro (NVRO) | United States | $0.451B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.413B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.375B | 0.00 |
| NeuroPace (NPCE) | United States | $0.361B | 0.00 |
| CVRx (CVRX) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 11.33 |
| AxoGen (AXGN) | United States | $0.303B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.273B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.267B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.254B | 0.00 |
| Accuray (ARAY) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.184B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.180B | 9.72 |
| Atossa Genetics (ATOS) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.150B | 0.00 |
| Neuronetics (STIM) | United States | $0.119B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.114B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.108B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.097B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Vasomedical (VASO) | United States | $0.055B | 9.83 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 108.33 |
| InspireMD (NSPR) | Israel | $0.052B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.049B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.036B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.016B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |